Essex Woodlands leads EUR30m Molecular Partners funding
Essex Woodlands Health Ventures has led a CHF46m (€30m) second round of funding in Swiss biotech business Molecular Partners, alongside existing investors Index Ventures, Johnson & Johnson Development Corporation, BB...